PDE10-IN-1
PDE10-IN-1 is a potent PDE10-IN-1 inhibitor extracted from Patent WO 2013192273 A1, for treating CNS and metabolic disorders.
Product Specifications
CAS Number
[1516896-09-5]
UNSPSC
12352005
Target
Phosphodiesterase (PDE)
Type
Reference compound
Related Pathways
Metabolic Enzyme/Protease
Applications
Neuroscience-Neuromodulation
Field of Research
Neurological Disease
Assay Protocol
https://www.medchemexpress.com/PDE10-IN-1.html
Purity
99.44
Solubility
DMSO : 2 mg/mL (ultrasonic)
Smiles
CC1=C([C@H]2[C@H](C3=NN4C(C(C)=NC=C4C)=N3)C2)N=C5C6=C(N=CC=C6)C=CN51
Molecular Formula
C21H19N7
Molecular Weight
369.42
References & Citations
[1]Campbell, John Emmerson, et al. Preparation of heteroaryl compounds as PDE-10 inhibitors for treating CNS and metabolic disorders. Patent WO 2013192273 A1 20131227.
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Isoform
PDE10
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
131604-Biotin 100 µL
PAPD7 (POLS, DNA Polymerase sigma, DNA Polymerase kappa, LAK-1, PAP-associated Domain-containing Protein 7, Terminal Uridylyltransferase 5, TUTase 5, Topoisomerase-related Function Protein 4-1, TRF4-1, TRF4, TUTASE5) (Biotin)
Ask
View Details 
MP0717X Each
Magic™ Membrane Protein Human MS4A2 (Membrane spanning 4-domains A2) for Antibody Discovery
Ask
View Details 044045-ML750 100 µL
ZDHHC13, NT (ZDHHC13, HIP14L, HIP3RP, Palmitoyltransferase ZDHHC13, Huntingtin-interacting protein 14-related protein, Huntingtin-interacting protein HIP3RP, Putative MAPK-activating protein PM03, Putative NF-kappa-B-activating protein 209, Zinc finger DHHC domain-containing protein 13) (MaxLight 750) discontinued
Ask
View Details 